Sutherlandia frutescens limits the development of insulin resistance by decreasing plasma free fatty acid levels

Phytotherapy Research

Volumn 23, Issue 11, 2009, Pages 1609-1614

  MacKenzie, Janine ^a   Koekemoer, Trevor ^a   Van De Venter, Maryna ^a   Dealtry, Gill ^a   Roux, Saartjie ^a  

^a NELSON MANDELA METROPOLITAN UNIVERSITY   (South Africa)

Author keywords

Diabetes; Dyslipidemia; Free fatty acids; Insulin resistance; Sutherlandia frutescens

Indexed keywords

ANTIDIABETIC AGENT; CHOLESTEROL; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PINOSUNDIA; PLANT EXTRACT; SUTHERLANDIA FRUTESCENS EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG ACTIVITY; FATTY ACID BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEGUME; LIPID DIET; MALE; NONHUMAN; RAT; SUTHERLANDIA FRUTESCENS; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; BLOOD GLUCOSE; CHOLESTEROL; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIETARY FATS; FABACEAE; FATTY ACIDS, NONESTERIFIED; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MALE; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, WISTAR;

RATTUS; SUTHERLANDIA FRUTESCENS;

EID: 70350455149     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2830     Document Type: Article

References (32)

1. Abbasi F, Brown BW, Lamendola C, McLaughlin T, Reaven GM. 2002. Relationship between obesity, insulin resistance, and coronary heart disease risk. J Am Coll Cardiol 40: 937-943. (Pubitemid 34994988)
2. Bickerton AS, Roberts R, Fielding BA et al. 2007. Preferential uptake of dietary fatty acids in adipose tissue and muscle in the postprandial period. Diabetes 56: 168-176. (Pubitemid 46263106)
3. Carpentier AC. 2008. Postprandial fatty acid metabolism in the development of lipotoxicity and type 2 diabetes. Diabetes Metab 34: 97-107.
4. Chadwick WA, Roux S, van de Venter M, Louw J, Oelofsen W. 2007 . Anti-diabetic effects of Sutherlandia frutescens in Wistar rats fed a diabetogenic diet. J Ethnopharmacol 109: 121-127. (Pubitemid 44822651)
5. Chinkwo KA. 2005. Sutherlandia frutescens extracts can induce apoptosis in cultured carcinoma cells. J Ethnopharmacol 98: 163-170.
6. Dealtry G, Coetzee C, Louw J, Roux S. 2008. High-fat diet in young rats increases PPAR gamma gene expression. JEMDSA 13: 28.
7. de Luca C, Olefsky JM. 2008. Inflammation and insulin resistance. FEBS Lett 582: 97-105.
8. Ebbeling CB, Pawlak DB, Ludwig DS. 2002. Childhood obesity: public-health crisis, common sense cure. Lancet 360: 473-482.
9. Fernandes AC, Cromarty AD, Albrecht C, van Rensburg CE. 2004. The antioxidant potential of Sutherlandia frutescens. J Ethnopharmacol 95: 1-5.
10. Friedewald WT, Levy RI, Fredrickson DS. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502.
11. Ginsberg HN. 1991. Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis. Diabetes Care 14: 839-855.
12. Ginsberg HN. 2000. Insulin resistance and cardiovascular disease. J Clin Invest 106: 453-458.
13. Ginsberg HN, Zhang YL, Hernandez-Ono A. 2005. Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res 36: 232-240. (Pubitemid 40755136)
14. Harnett SM, Oosthuizen V, van de Venter M. 2005. Anti-HIV activities of organic and aqueous extracts of Sutherlandia frutescens and Lobostemon trigonus. J Ethnopharmacol 96: 113-119. (Pubitemid 39575039)
15. Johnson Q, Syce J, Nell H, Rudeen K, Folk WR. 2007. A randomized, double-blind, placebo-controlled trial of Lessertia frutescens in healthy adults. PLoS Clin Trials 2: e16. (Pubitemid 46851660)
16. Katz A, Nambi SS, Mather K et al. 2000. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85: 2402-2410. (Pubitemid 32269192)
17. Kovacs P, Stumvoll M. 2005. Fatty acids and insulin resistance in muscle and liver. Best Pract Res Clin Endocrinol Metab 19: 625-635. (Pubitemid 41819222)
18. Matsuzawa-Nagata N, Takamura T, Ando H et al. 2008. Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity. Metabolism 57: 1071-1077. (Pubitemid 351978066)
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419. (Pubitemid 15018832)
20. Milligan G, Stoddart LA, Brown AJ. 2006. G protein-coupled receptors for free fatty acids. Cell Signal 18: 1360-1365. (Pubitemid 43842097)
21. Mlinar B, Marc J, Janez A, Pfeifer M. 2007. Molecular mechanisms of insulin resistance and associated diseases. Clin Chim Acta 375: 20-35. (Pubitemid 44584240)
22. Mook S, Halkes Ci C, Bilecen S, Cabezas MC. 2004. In vivo regulation of plasma free fatty acids in insulin resistance. Metabolism 53: 1197-1201.
23. Ojewole JA. 2004. Analgesic, antiinflammatory and hypoglycemic effects of Sutherlandia frutescens R. BR. (variety Incana E. MEY.) [Fabaceae] shoot aqueous extract. Methods Find Exp Clin Pharmacol 26: 409-416.
24. Pirola L, Johnston AM, Van Obberghen E. 2004. Modulation of insulin action. Diabetologia 47: 170-184.
25. Qatanani M, Lazar MA. 2007. Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev 21: 1443-1455. (Pubitemid 46955717)
26. Randle PJ, Garland PB, Hales CN, Newsholme EA. 1963. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1: 785-789.
27. Sia C. 2004. Spotlight on ethnomedicine: usability of Sutherlandia frutescens in the treatment of diabetes. Rev Diabet Stud 1: 145-149.
28. Stander BA, Marais S, Steynberg TJ et al. 2007. Influence of Sutherlandia frutescens extracts on cell numbers, morphology and gene expression in MCF-7 cells. J Ethnopharmacol 112: 312-318. (Pubitemid 46756075)
29. Tai J, Cheung S, Chan E, Hasman D. 2004. In vitro culture studies of Sutherlandia frutescens on human tumor cell lines. J Ethnopharmacol 93: 9-19.
30. van Wyk BE, Albrecht C. 2008. A review of the taxonomy, ethnobotany, chemistry and pharmacology of Sutherlandia frutescens (Fabaceae). J Ethnopharmacol 119: 620-629.
31. Wang CC, Goalstone ML, Draznin B. 2004. Molecular mechanisms of insulin resistance that impact cardiovascular biology. Diabetes 53: 2735-2740. (Pubitemid 39425897)
32. Williams S, Dealtry G, van de Venter M, Roux S. 2008. Genetic analysis of insulin resistance in a human hepatocyte cell line. JEMDSA 13: 43.